KKR, Temasek eyeing $100m Healthcare Global Enterprises investment


Global buyout house KKR and Singapore sovereign wealth investor Temasek are in talks to help Indian cancer care specialist Healthcare Global Enterprises raise $100m, it is understood.

Some of the funding will be used to buy out the stakes of other investors including Milestone Religare, Premji Invest and fund of funds Evolvence India Fund, according to DealCurry.

It said Premji had previously invested $20m in Banglaire-based HCG, while Milestone had parted with $6.85m through its India Build Out Fund I.

HCG has a network of 25 cancer centres across India and Africa and says it treats more than 30,000 new patients each year.

India’s healthcare sector has attracted continues investment from private equity and venture capital over the past 12 months as investors look to capitalise on the country’s increasing middle class.

Last month Norwest Venture Partners invested $22.5m in Indian medical diagnostics company Thyrocare Technologies to help expand the business.

NVP managing director Sohil Chand will join the Thyrocare board of directors as part of the deal, which follows a previous investment from CX Partners.

Copyright © 2012 AltAssets